vs

Side-by-side financial comparison of ABEONA THERAPEUTICS INC. (ABEO) and GSK plc (GSK). Click either name above to swap in a different company.

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of novel gene and cell therapies for life-threatening rare genetic diseases. Its pipeline addresses unmet medical needs, serving patient populations across North America and European markets with limited treatment alternatives.

GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABEO
ABEO
GSK
GSK
Q3 25
$0
Q2 25
$400.0K
Net Profit
ABEO
ABEO
GSK
GSK
Q3 25
$-5.2M
Q2 25
$108.8M
Operating Margin
ABEO
ABEO
GSK
GSK
Q3 25
Q2 25
-5698.0%
Net Margin
ABEO
ABEO
GSK
GSK
Q3 25
Q2 25
27208.3%
EPS (diluted)
ABEO
ABEO
GSK
GSK
Q3 25
$-0.10
Q2 25
$1.71

Related Comparisons